Miras, Alexander Dimitri

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

Miras, A. D., Pérez-Pevida, B., Aldhwayan, M., Kamocka, A., McGlone, E. R., Al-Najim, W., Chahal, H., Batterham, R. L., McGowan, B., Khan, O., et al. (2019) · The Lancet Diabetes & Endocrinology

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 190

Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task

Miras, A. D., Jackson, R. N., Jackson, S. N., Goldstone, A. P., Olbers, T., Hackenberg, T., Spector, A. C., & le Roux, C. W. (2012) · The American Journal of Clinical Nutrition

Bariatric Surgery and OutcomesRegulation of Appetite and Obesity

Cited by 162

Mechanisms of Weight Loss After Obesity Surgery

Akalestou, E., Miras, A. D., Rutter, G. A., & le Roux, C. W. (2022) · Endocrine Reviews

Bariatric Surgery and OutcomesRegulation of Appetite and Obesity

Cited by 136

Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity

Goldstone, A. P., Miras, A. D., Scholtz, S., Jackson, S., Neff, K. J., Pénicaud, L., Geoghegan, J., Chhina, N., Durighel, G., Bell, J. D., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism

Bariatric Surgery and OutcomesRegulation of Appetite and Obesity

Cited by 121

The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conference

Luli, M., Yeo, G., Farrell, E., Ogden, J., Parretti, H., Frew, E., Bevan, S., Brown, A., Logue, J., Menon, V., et al. (2023) · eClinicalMedicine

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 66

The efficacy of GLP‐1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review

Llewellyn, D. C., Logan Ellis, H., Aylwin, S. J. B., Oštarijaš, E., Green, S., Sheridan, W., Chew, N. W. S., le Roux, C. W., Miras, A. D., Patel, A. G., et al. (2023) · Obesity

Bariatric Surgery and OutcomesDiabetes Management and Research

Cited by 54

Future therapies for obesity

Melson, E., Miras, A. D., & Papamargaritis, D. (2023) · Clinical Medicine

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 46

“From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services

Brown, A., Mellor, D., Makaronidis, J., Shuttlewood, E., Miras, A. D., & Pournaras, D. J. (2024) · Nutrition Bulletin

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 9

Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery

Sharma, M., Nayar, R., Graham, Y., Parretti, H. M., Abbott, S., Tahrani, A., Miras, A. D., Madhok, B., Singhal, R., & Mahawar, K. (2022) · Obesity Surgery

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 5